literature still claims that the pathogenesis and/or pathophysiology of endometriosis is unclear. Studies have shown that the growth and progression of endometriosis continue even in an ovariectomized animal. This indicates that besides ovarian steroid hormones, the growth of endometriosis can be regulated by the innate immune system in the pelvic environment. As a component of the innate immune system, increased infiltration of macrophages (Mφ) has been described in the intact tissue and peritoneal fluid (PF) of women with endometriosis. 5 The understanding of the innate immune system is a result, in large part, from the pioneering studies of Charles Janeway, who demonstrated that innate immunity covers many areas of host defense against pathogenic microbes. 6 During the last decade, investigations of the innate immune system have shown that microbial pathogens are recognized by Toll-like receptors (TLRs) that, in turn, regulate the activation of both innate and adaptive immunity. 
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Originally described over 300 years ago, endometriosis is classically defined by the presence of endometrial glands and stroma in extrauterine locations. 1 Endometriosis is an estrogen-dependent disease that mostly affects women of reproductive age. Recently, it has been demonstrated that besides hormonal regulation, both secondary (cytokines/growth factors) and initial inflammatory (LPS) mediators are known to be involved in the growth of endometriosis. 2, 3, 10 Some of the literature, including the authors', has demonstrated the expression of TLRs in Mφ and other dendritic cells. [11] [12] [13] [14] This review article will discuss: (1) a fundamental concept of the TLR system for easy understanding by the readers, (2) the biological function of the initial inflammatory mediator, bacterial endotoxin or LPS, in the eutopic and ectopic endometria, (3) confirmation of the presence of LPS in the pelvic environment, (4) the source of LPS in menstrual blood, (5) the mechanistic basis of bacterial contamination in the intrauterine environment, (6) cross-talk between inflammation and the stress reaction in endometriosis, (7) cross-talk between ovarian steroids and inflammation in endometriosis, (8) the cause-effect of endometriosis on bacterial contamination, (9) the association of intrauterine microbial colonization (IUMC) in women treated and untreated with an estrogen-suppressing agent, (10) intrauterine microbial colonization after treatment with an estrogen-suppressing agent, and (11) the possible association of intrauterine bacterial contamination with the reproductive outcome.
| TOLL-LIKE RECEPTOR SYSTEM

| Toll-like receptor family
Until recently, 11 different members have been reported in the family of mammalian TLRs. Among them, TLRs1-9 are conserved between the human and the mouse. 14,15 TLR10 appears to be functional in the human, but non-functional in the mouse. On the contrary, mouse TLR11 appears to be functional, but non-functional in the human. 16 Initially, a potential role of TLR4 was established in the recognition of the microbial component. 17 However, subsequent studies revealed important roles of the individual TLRs in recognizing specific microbial components that are derived from pathogens, including bacteria, fungi, protozoa, and viruses. A detailed description of the different TLRs, their respective ligands, and their intracellular mode of action already have been reported. 9, 18, 19 Here, we focus on the role of TLR4 in endometriosis.
| Ligands of Toll-like receptor 4
There are two types of ligands, exogenous and endogenous, for TLR4. 20 Bacterial endotoxin or LPS, F protein from the respiratory syncytial virus, chlamydial heat shock protein (Hsp)60, and taxol, a plant-derived anticancer reagent, all belong to the exogenous ligands of TLR4. The action of taxol mimics the action of LPS in mice but not in humans. 20 The endogenous ligands of TLR4 comprise fibrinogen, fibronectin, heparin sulphate, hyaluronic acid, and Hsps60 and 70. Although a minimal concentration of LPS has the ability to activate TLR4, all the endogenous ligands need very high concentrations to activate TLR4.
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| Signaling pathways that are triggered by Toll-like receptor 4
The detailed signaling pathways of TLR4 in response to LPS are described elsewhere. 24, 25 It seems that all the TLR signaling pathways are similar and elicit similar biological responses, except TLR3.
Lipopolysaccharide is immediately captured by LPS-binding protein that delivers LPS to TLR4 or CD14 soon after its release in bodily fluids.
Lipopolysaccharide is a potent activator of Mφ and other dendritic cells.
Different monocyte markers, including CD14, lack a trans-membrane domain and thus are incapable of transducing signals. 26 Once LPS/ TLR4 binds with TLR4, it stimulates a cascade of intracellular adopter molecules and triggers the gene expression of a number of target molecules (cytokines/chemokines/growth factors) by inducing nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) activation. are the most commonly isolated pathogenic bacteria in the bovine and also in the human vaginal cavity. 28, 29 It is speculated that the ascending migration of E. coli towards the endometrial cavity is possible and may cause contamination of the endometrium, based on the phases of the menstrual cycle. 
| BIOLOGICAL FUNCTION OF LIPOPOLYSACCHARIDE IN ENDOMETRIOSIS
The function of LPS in Mφ, endometrial, and endometriotic cells has Another study indicated that the TLR4 system might represent local immunity in the human endometrium, with different modes of TLR4 actions between the ESCs and the EECs. 31 As a secondary inflammatory mediator, different macromolecules (cytokines/chemokines/growth factors) in the pelvic environment are believed to enhance the growth of endometriosis.
The authors reported that as an initial inflammatory mediator, bacterial endotoxin (LPS) could be a potential inflammatory mediator of Mφ stimulation and the consequent production of HGF, VEGF, IL-6, and TNF-α in the pelvic environment. 11, 36 This LPS, together with LPS-induced secondary inflammatory mediators, are possibly involved in the growth of endometriosis in an autocrine or paracrine mechanism. 36, 37 In addition to TLR4 blocking, the stimulating effect of LPS can be abrogated after treatment with NF-kB inhibitor. 37 This was confirmed in another experiment using ESCs that had been derived from chocolate cyst linings of the ovary. The authors demonstrated that NF-kB inhibitor was able to significantly suppress LPS-stimulated TNF-α and IL-8 production by ESCs, as well as ESC proliferation. This indicates that as an initial inflammatory mediator, the functional activity of LPS is regulated by both TLR4 at the receptor level on the cell surface and by NF-kB at the nucleus. It is presumed that a substantial amount of endotoxin in the menstrual fluid (MF) and PF could be involved in pelvic inflammation and could promote the TLR4/NF-kB-mediated growth of endometriosis.
| PRESENCE OF LIPOPOLYSACCHARIDE IN THE INTRAUTERINE AND PELVIC ENVIRONMENT
The authors examined the endotoxin concentration for the first time in the MF and PF of women with or without endometriosis. The limulus amoebocyte lysate test was used to measure the endotoxin levels in the PF that had been collected from women with and without endometriosis. With informed consent and a strict aseptic measure, menstrual blood was collected from a proportion of these women.
It was found that the endotoxin (LPS) concentration in the MF was four-to-sixfold, and significantly higher, in the women with endometriosis than that in those without endometriosis. 11 Regarding the distributed endotoxin concentration in the PF, based on the phases of the menstrual cycle, a maximum concentration during the menstrual phase and a modest concentration in either the proliferative or the secretory phase of the menstrual cycle was found. 
| SOURCE OF LIPOPOLYSACCHARIDE IN THE MENSTRUAL BLOOD
The residual accumulation of bacterial endotoxin in the pelvic environment can be explained by two possible mechanisms: (1) the translocation of E. coli or endotoxin from the gut through enterocytes and their entry into the pelvic cavity, as demonstrated in one study, 38 and (2) contamination of the menstrual blood by E. coli after ascending migration from the vagina. The authors confirmed, by the bacterial culture method, that the menstrual blood of women with endometriosis was highly contaminated with E. coli, compared to that in the control women. 11 These findings suggested that the contamination of menstrual blood with E. coli in women with endometriosis could be a constant source of bacterial endotoxin in the PF because of a periodic retrograde menstrual flow and that this cyclic event could initiate the TLR4-mediated growth of endometriosis.
| MECHANISTIC BASIS OF BACTERIAL CONTAMINATION IN THE MENSTRUAL BLOOD
The authors have proposed two mechanisms that were involved in the E. coli contamination of the menstrual blood: (1) higher prostaglandin E 2 (PGE 2 ) levels in the MF and PF of women with endometriosis was involved in the bacterial growth of E. coli in a bacterial culture system 39 and that this effect of PGE 2 on bacteria might be contributed to by its direct growth-promoting effect on E. coli or by its indirect immunosuppression effect on peripheral blood lymphocytes 39 and (2) 
| CROSS-TALK BETWEEN INFLAMMATION AND THE STRESS REACTION IN ENDOMETRIOSIS
Endometrial tissue degradation during menstruation, its backflow, and consequent attachment or invasion into the pelvis conferred a physical or chemical tissue stress reaction in women who suffered from endometriosis. Other stressful stimuli, such as heat shock, UV radiation, viral or bacterial infections, and pelvic inflammation, induced an increase in the intracellular synthesis of stress-induced proteins, such as Hsps.
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The so-called "danger theory" states that antigen-presenting cells can be activated by endogenous substances that are released by damaged or stressful tissues 46 and that this effect of Hsps has been reported to be mediated by TLR4, either alone or in combination with LPS. 36 The authors' recent study demonstrated the release of a variable amount of endogenous Hsp70 by the different peritoneal lesions and eutopic endometria of women with endometriosis. It was found that Hsp70 induced TLR4-mediated inflammation and the growth of endometriosis. 36 Although polymyxin B was unable to suppress the combined LPS-and Hsp70-mediated growth of endometriosis, the growth-promoting effect of combined LPS and Hsp70 was significantly suppressed when the biological function of TLR4 was blocked with anti-TLR4 antibody. 36 This indicates that the LPS-and Hsp70-mediated inflammatory reaction and growth of endometriosis could be mediated by TLR4 in the pelvic environment.
Oxidative stress is another form of tissue stress reaction that results from excessive iron accumulation in the endometriotic fluid.
Endometriotic lesions, including chocolate cysts and blood-filled opaque red lesions, are hemorrhagic during menstruation. 46, 47 Oxidative stress is related to atherosclerosis, neurodegeneration, cancer, and aging. [48] [49] [50] Excessive reactive oxygen species (ROS) production or oxidative stress might be associated with endometriosis.
Recently, it has been demonstrated that in addition to the effects of endogenous danger signals via TLRs, tissue oxidative stress itself can promote the NF-kB-or TLR4-mediated growth of endometriosis. 51 In fact, LPS itself has the capacity to produce ROS by Mφ. These findings are consistent with the understanding that LPS, endogenous danger signals, and oxidative stress could promote the onset and progression of endometriosis after the activation of TLRs and/or NF-kB signaling.
| CROSS-TALK BETWEEN OVARIAN STEROIDS AND INFLAMMATION IN ENDOMETRIOSIS
The effect of estrogen, either alone or in combination with initial or secondary inflammatory mediators, on the growth regulation of endometriosis has been reported. [52] [53] [54] [55] The authors previously demonstrated the Mφ-mediated production of HGF, VEGF, IL-6, and TNF-α in response to ovarian steroids, which was further enhanced after treatment with LPS. 52, 54 An additive effect was observed between E2 and LPS on the Mφ-mediated secretion of macromolecules and on the proliferation of eutopic and ectopic endometrial stromal cells, when compared with their single treatment. [53] [54] [55] This effect of E2 plus LPS on cell growth was markedly abrogated after pretreatment of the cells with anti-TLR4 antibody and intracervical insemination, an estrogen antagonist. 53, 54 These findings suggested that E2 exhibited a pro-inflammatory response and that an immune-endocrine cross-talk between estrogen and endotoxin in the pelvic environment could be involved as an additive inflammatory response in the pelvic environment and growth of endometriosis.
| CAUSE-EFFECT OF ENDOMETRIOSIS ON BACTERIAL CONTAMINATION
| Scattering of endometrial cells and increased cell motility or invasion by lipopolysaccharide-induced hepatocyte growth factor
The most critical question may arise now: "Is this bacterial contamination the effect of endometriosis or the cause of endometriosis?"
Based on the authors' serial experiments, the conclusion is that bacterial contamination in menstrual blood could be the effect of endometriosis and, at the same time, also might develop endometriosis. It was demonstrated that LPS regulates the expression of HGF and its receptor, c-Met, in the PF, ESCs, and EECs. endometriosis, compared to the GnRHa-untreated women. 59 The authors examined the pattern of bacterial growth in the endometrial samples that had been derived from the GnRHa-treated and -untreated women with and without endometriosis, using the bacterial culture method. Among the colony formations of nine different microbial species, according to the treatment status of GnRHa, a significantly increased colony formation was found of Gardnerella and E. coli (P < 0.05 for each) in the GnRHa-treated control women and Gardnerella, Enterococci, and E. coli (P < 0.05 for each) was found in the GnRHa-treated women with endometriosis, compared to the GnRHauntreated women. 59 A Kruskal-Wallis test still indicated a higher growth of these microbial species after GnRHa treatment than other microbes. The microbial growth of lactic acid-producing protective . 59 From these recent findings, it is presumed that a worsening of IUMC and a higher occurrence of endometritis could occur in women with endometriosis after GnRHa treatment. These findings of the association between endometriosis and chronic endometriosis were supported by two recently published reports.
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| ASSOCIATION OF BACTERIAL CONTAMINATION OR ENDOMETRITIS WITH THE REPRODUCTIVE OUTCOME
The common problems of women who suffer from endometriosis are an impairment in the quality of life and producing a state of subfertility or infertility. A number of mechanisms have been proposed to support these adverse effects of endometriosis. [64] [65] [66] [67] [68] [69] As endometriosis is a chronic inflammatory disease, a moderate-tosevere inflammatory reaction in the pelvic environment of women with endometriosis leads to the formation of tubo-ovarian adhesion or peri-tubal adhesion, finally resulting in the narrowing or occlusion of the Fallopian tubes. [66] [67] [68] On the contrary, bacterial endotoxin (LPS) that has been derived from Gram-negative bacteria can directly cause endometrial or tubal damage. Endotoxin has been found to be deleterious to pre-implantation stage embryos. 70 The presence of endotoxin in in vitro fertilization (IVF) culture media results in a high rate of polyspermy, decreased embryo cleavage rate, and blastocyst formation in human and bovine species. 70 A recent assisted reproductive technology clinical trial demonstrated that the pregnancy rate after IVF-embryo transfer was significantly higher in those women with an endotoxin level of <200 pg/mL in the MF than in the women with an endotoxin level of >200 pg/ mL. 69 All these accumulated findings indicate that, in addition to an inflammatory reaction, different ligands that are derived from different microbes in the intrauterine environment can induce a variable detrimental effect on the reproductive outcome and that this adverse effect also could occur in women with endometriosis.
Endotoxin also possesses the capacity to induce the apoptosis of cells by impairing sperm motility and inducing spermicidal activity. 70 A recent study demonstrated the expression of TLR4 and TLR2 in human and mouse sperm and measured suboptimal concentrations of endotoxin and peptidoglycan in human semen. 70 It was found that the addition of LPS (the ligand of TLR4) and peptidoglycan (the ligand of TLR2) in the absence of leukocytes directly and significantly reduced the motility and increased the apoptotic rate of both human and mouse sperm and suppressed fertilization by sperm both in vivo and in vitro. 70 These findings further strengthened the detrimental effect of bacterial endotoxin on the reproductive outcome.
Recently, an elegant effort was made to find the evidence that the endometrial microbiota has an effect on implantation success or failure. The molecular detection of microbiota in the endometrial fluid demonstrated the existence of an endometrial microbiota that is highly stable during the acquisition of endometrial receptivity. 71 When bacterial communities from paired endometrial fluid and vaginal aspirate samples within the same women were analyzed, different bacterial communities were identified between the uterine cavity and the vagina of some participants. A similar study also found that the presence of a range of microbial candidates in a receptive endometrium was associated with significant decreases in implantations, pregnancies, ongoing pregnancies, and live birth rates in infertile women who were undergoing IVF. 71 These findings further added an association between intrauterine microbial colonization and an adverse reproductive outcome.
Chronic endometritis (CE) was found to be a frequent finding in the women with recurrent implantation failure (RIF) after IVF. A CE 
| CONCLUSION
The 
